ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,528,000 | -53.7% | 227,600 | -72.7% | 0.27% | -60.4% |
| Q3 2019 | $35,692,000 | +606.1% | 834,313 | +948.0% | 0.68% | +767.9% |
| Q2 2019 | $5,055,000 | -2.7% | 79,607 | +17.8% | 0.08% | +25.8% |
| Q2 2018 | $5,197,000 | -56.3% | 67,605 | -60.1% | 0.06% | -59.2% |
| Q4 2016 | $11,903,000 | -0.9% | 169,300 | 0.0% | 0.15% | +10.9% |
| Q3 2016 | $12,010,000 | +45.0% | 169,300 | 0.0% | 0.14% | +59.3% |
| Q2 2016 | $8,280,000 | +1.9% | 169,300 | +32.0% | 0.09% | +1.2% |
| Q1 2016 | $8,123,000 | – | 128,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |